In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis

International Journal of Antimicrobial Agents

Volumn 22, Issue 5, 2003, Pages 497-501

  Küçükbasmaci, Ömer ^a   Gönüllü, Nevriye ^a   Aktaş, Zerrin ^b   Gürol, Dilara ^b   Berkiten, Rahmiye ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Fluoroquinolones; Haemophilus influenzae; Macrolides; Moraxella catarrhalis; Streptococcus pneumoniae; Telithromycin

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; GEMIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPECIES COMPARISON; STREPTOCOCCUS PNEUMONIAE;

EID: 0242290103     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00150-X     Document Type: Article

References (15)

1. Bartlett J.G., Dowell S.F., Mandell L.A., File T.M. Jr., Musher D.M., Fine M.J. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin. Infect. Dis. 31:2000;347-382.
2. Hoban D.J., Doern G.V., Fluit A.C., Roussel-Delvallez M., Jones R.N. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32:(Suppl. 2):2001;S81-S93.
3. Felmingham D., Feldman C., Hryniewicz W., et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin. Microbiol. Infect. 8:(Suppl. 2):2002;12-42.
4. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-AG. Wayne, PA: NCCLS, 2000.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 12th informational supplement M100-S12. Wayne, PA: NCCLS, 2002.
6. Wise R., Andrews J.M. The in vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone. J. Antimicrob. Chemother. 44:1999;679-688.
7. Thornsberry C., Jones M.E., Hickey M.L., Mauriz Y., Kahn J., Sahm D.F. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. J. Antimicrob. Chemother. 44:1999;749-759.
8. Sener B., Gunalp A. Trends in antimicrobial resistance of Streptococcus pneumoniae in children in a Turkish hospital. J. Antimicrob. Chemother. 42:1998;381-384.
9. Kanra G., Erdem G., Ceyhan M., Klugman K.P., Vasas A. Serotypes and antibacterial susceptibility of pneumococci isolated from children with infections in Ankara in relation to proposed pneumococcal vaccine coverage. Acta Paediatr. Jpn. 40:1998;437-440.
10. Felmingham D., Gruneberg R.N. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J. Antimicrob. Chemother. 45:2000;191-203.
11. Gonullu N., Berkiten R. Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Istanbul. Int. J. Antimicrob. Agents. 16:2000;77-78.
12. Wootton M., Bowker K.E., Janowska A., Holt H.A., MacGowan A.P. In vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci. J. Antimicrob. Chemother. 44:1999;445-453.
13. Hoban D.J., Zhanel G.G., Karlowsky J.A. In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Diagn. Microbiol. Infect. Dis. 35:1999;37-44.
14. Gur D., Ozalp M., Sumerkan B., et al. Prevalence of antimicrobial resistance in Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey. Int. J. Antimicrob. Agents. 19:2002;207-211.
15. Pankuch G.A., Hoellman D.B., Lin G., Bajaksouzian S., Jacobs M.R., Appelbaum P.C. Activity of HMR 3647 compared with those of five agents against Haemophilus influenzae and Moraxella catarrhalis by MIC determination and time-kill assay. Antimicrob. Agents Chemother. 42:1998;3032-3034.